Friday, August 26, 2016

Genomic tools and the era of tailored treatment in breast cancer

… stage breast cancer.
The MINDACT trial confirmed that patients with certain breast cancers, who … for breast cancer. It will become routine in the future for all breast cancers … or 2 breast cancer, which is the most common presentation of breast cancer in …

No comments:

Post a Comment